Metraipolis › archive › dc_0f18378d6432

Reduced immunogenicity of MYC amplified, metastatic prostate cancer — Europe PMC PMID:41743583

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41743583
DOI
10.18632/oncoscience.644
License (as archived)
solo-consultazione
Archived
2026-11-06T01:12:28.176Z
SHA-256 of the archived text
d8f99f91b8f3ad3b76b5b4d22a8c4297a2f677ecda47d7a5df96ae170efbe26e
Stable URL of this page
https://metraipolis.com/documento/dc_0f18378d6432

How to cite

Reduced immunogenicity of MYC amplified, metastatic prostate cancer — Europe PMC PMID:41743583 — Europe PMC (en), https://europepmc.org/article/MED/41743583 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0f18378d6432 (Metraipolis archive dc_0f18378d6432, sha256 d8f99f91b8f3ad3b76b5b4d22a8c4297a2f677ecda47d7a5df96ae170efbe26e)
BibTeX
@misc{dc0f18378d6432,
  title = {Reduced immunogenicity of MYC amplified, metastatic prostate cancer — Europe PMC PMID:41743583},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41743583},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0f18378d6432; sha256 d8f99f91b8f3ad3b76b5b4d22a8c4297a2f677ecda47d7a5df96ae170efbe26e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41743583. Agents can read the archived copy with the MCP tool read_document.